Skip to content
2000
Volume 15, Issue 12
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Post-translational modifications (PTMs) play important roles in regulating protein stability, trafficking, folding conformation, and functional activity. Small ubiquitin-like modifier (SUMO) protein mediates a distinct type of PTM called SUMOylation in which the SUMO protein is covalently ligated to the target protein and modifies its activities through a series of enzymatically-catalyzed reactions. SUMOylation regulates many cellular processes like transcription, the maintenance of the ion gradient across the cell membrane, stress response, autoimmunity, etc. Several target proteins of SUMOylation are involved in the biological pathways related to various human diseases, including cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders. This review focuses on the SUMOylation process, regulatory roles of SUMOylation in diabetes, and prospects of developing novel anti-diabetic drugs targeting the SUMOylation process.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450115666140915124747
2014-11-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450115666140915124747
Loading

  • Article Type:
    Research Article
Keyword(s): Diabetes; post-translational modification; SUMO inhibitors; SUMO targets; SUMOylation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test